Should You Buy Johnson & Johnson Stock Before July 16th?

Johnson & Johnson (JNJ -0.05%) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion. Known for its long-term stability and dividend growth, it's a blue chip stock that is primarily suitable for risk-averse investors who want to collect a reliable payout. Johnson & Johnson last reported earnings on April 15, which covered the first three months of the year. Its sales were up by a little over 2%, totaling $21.9 bill ...